Can-Fite BioPharma CANF
NYSE CANF
$2.24 +0.04 (+1.82%)
As of: Oct 1, 2026 · 3:59 PM EDT

Can-Fite BioPharma (CANF) Accumulated Expenses (2016 - 2024)

Updated

Can-Fite BioPharma's Accumulated Expenses was $301,000 in Q4 2024, up 20.4% from $250,000 a year earlier.

Analysis

Can-Fite BioPharma (CANF) Accumulated Expenses (2016 - 2024) Analysis & Trends

From Q4 2016 onward, Can-Fite BioPharma has reported Accumulated Expenses for 6 quarters.

  • Accumulated Expenses shows a five-year compound annual growth rate of -7.5% (FY2019 to FY2024).
  • In earlier years, Accumulated Expenses was $250,000 in FY2023.
  • The Q4 2024 figure marks the highest quarterly Accumulated Expenses since Q4 2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Can-Fite BioPharma 1.82 Mn -17.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 301,000.00
Dec 31, 2023 250,000.00
Dec 31, 2019 445,000.00
Dec 31, 2018 973,000.00
Dec 31, 2017 772,000.00
Dec 31, 2016 829,000.00
API Access

Can-Fite BioPharma Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CANF&period=max&api_key=YOUR_API_KEY